These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15173512)

  • 41. [Implementation of the neonatal cystic fibrosis screening program in Switzerland: beginning January 2011].
    Mornand A; Barben J; Hafen G
    Rev Med Suisse; 2011 Feb; 7(283):456, 458-60. PubMed ID: 21452515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequency of intron 8 CFTR polythymidine sequence variant in neonatal blood specimens.
    Chin S; Ranieri E; Gerace RL; Nelson PV; Carey WF
    Lancet; 1997 Nov; 350(9088):1368-9. PubMed ID: 9365460
    [No Abstract]   [Full Text] [Related]  

  • 43. Cystic fibrosis: refining the approach to newborn screening.
    Wilcken B
    J Pediatr; 2009 Nov; 155(5):605-6. PubMed ID: 19840611
    [No Abstract]   [Full Text] [Related]  

  • 44. Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process.
    Munck A; Delmas D; Audrézet MP; Lemonnier L; Cheillan D; Roussey M
    J Med Screen; 2018 Mar; 25(1):6-12. PubMed ID: 28454512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implementation of newborn screening for cystic fibrosis in Norway. Results from the first three years.
    Lundman E; Gaup HJ; Bakkeheim E; Olafsdottir EJ; Rootwelt T; Storrøsten OT; Pettersen RD
    J Cyst Fibros; 2016 May; 15(3):318-24. PubMed ID: 26795017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A continuing role for sweat testing in an era of newborn screening for cystic fibrosis.
    Kirk JM
    Clin Biochem; 2011 May; 44(7):487-488. PubMed ID: 22036339
    [No Abstract]   [Full Text] [Related]  

  • 47. First case of cystic fibrosis in Greenland - diagnosed by neonatal screening.
    M S; A K; M D
    J Cyst Fibros; 2020 May; 19(3):e14-e15. PubMed ID: 32089517
    [No Abstract]   [Full Text] [Related]  

  • 48. Emerging issues in cystic fibrosis newborn screening.
    Castellani C; Massie J
    Curr Opin Pulm Med; 2010 Nov; 16(6):584-90. PubMed ID: 20814308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Systematic neonatal screening].
    Guillot M; Travert G; Roussey M; Figarella C; Vidailhet M
    Arch Pediatr; 2001 Dec; 8 Suppl 5():833s-837s. PubMed ID: 11811052
    [No Abstract]   [Full Text] [Related]  

  • 50. Newborn screening for cystic fibrosis: do we need a second IRT?
    Price JF
    Arch Dis Child; 2006 Mar; 91(3):209-10. PubMed ID: 16492882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening.
    Kay DM; Langfelder-Schwind E; DeCelie-Germana J; Sharp JK; Maloney B; Tavakoli NP; Saavedra-Matiz CA; Krein LM; Caggana M; Kier C;
    Pediatr Pulmonol; 2015 Aug; 50(8):771-80. PubMed ID: 26098992
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cystic Fibrosis Diagnosis and Newborn Screening.
    Rosenfeld M; Sontag MK; Ren CL
    Pediatr Clin North Am; 2016 Aug; 63(4):599-615. PubMed ID: 27469178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Low-Cost and Simple Genetic Screening for Cystic Fibrosis Provided by the Brazilian Public Health System.
    Rispoli T; Martins de Castro S; Grandi T; Prado M; Filippon L; Dornelles da Silva CM; Vargas JE; Rossetti LMR
    J Pediatr; 2018 Aug; 199():272-277.e3. PubMed ID: 29731357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prenatal and newborn screening for CFTR mutations: the difficulties of prediction.
    Schwarz MJ
    Clin Biochem; 2011 May; 44(7):485-486. PubMed ID: 22036338
    [No Abstract]   [Full Text] [Related]  

  • 55. [Cystic fibrosis and neonatal screening].
    Nau JY
    Rev Med Suisse; 2007 May; 3(110):1212. PubMed ID: 17564353
    [No Abstract]   [Full Text] [Related]  

  • 56. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
    Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
    J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CFTR2: How will it help care?
    Castellani C;
    Paediatr Respir Rev; 2013 May; 14 Suppl 1():2-5. PubMed ID: 23466340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of the entire coding region of the cystic fibrosis transmembrane regulator gene in neonatal hypertrypsinaemia with normal sweat test.
    Castellani C; Benetazzo MG; Tamanini A; Begnini A; Mastella G; Pignatti P
    J Med Genet; 2001 Mar; 38(3):202-5. PubMed ID: 11303517
    [No Abstract]   [Full Text] [Related]  

  • 59. Comprehensive genetic analysis of the cystic fibrosis transmembrane conductance regulator from dried blood specimens--implications for newborn screening.
    Kammesheidt A; Kharrazi M; Graham S; Young S; Pearl M; Dunlop C; Keiles S
    Genet Med; 2006 Sep; 8(9):557-62. PubMed ID: 16980811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sweat chloride testing in infants identified as heterozygote carriers by newborn screening.
    Soultan ZN; Foster MM; Newman NB; Anbar RD
    J Pediatr; 2008 Dec; 153(6):857-9. PubMed ID: 19014821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.